[ad_1] Novavax Inc. NVAX reported positive results from three vaccine trials on Tuesday, one targeting both COVID and flu, one for stand-alone flu and…
[ad_1] While many have been focused on the apparent explosion of COVID cases in China, and the lack of reliable data from China’s government,…
[ad_1] Novavax Inc. Novavax, Inc. focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It provides vaccines for COVID-19, seasonal…
[ad_1] The White House has unveiled a fresh push to increase COVID preparedness heading into the holidays and will again make free tests available…
[ad_1] The head of the International Monetary Fund on Tuesday joined the chorus of people urging China to adopt a more targeted approach to…
[ad_1] A fresh analysis of data on the immune response generated by the bivalent COVID-19 booster showed strong results against the newer omicron sublineages,…
[ad_1] Shares of Novavax Inc. NVAX, -3.17% were up 2.4% in premarket trading on Friday after the company said its COVID-19 booster was authorized…
[ad_1] The southern Chinese manufacturing hub of Guangzhou is the latest to see lockdowns amid a surge in COVID-19 cases, as the government presses…
[ad_1] The Centers for Disease Control and Prevention has refuted claims that it’s planning to add the COVID-19 vaccine to immunization schedules for schoolchildren,…
[ad_1] Pfizer Inc. PFE, +4.17% said Thursday that it plans to sell the COVID-19 shot it developed with BioNTech SE BNTX, +7.14% for $110…
